Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial

The 2019 landmark PIVOTAL trial that established the safety and efficacy of higher-dose iron in patients on hemodialysis had little discernable impact on US practice, which already used higher doses.
Medscape Medical News

source https://www.medscape.com/viewarticle/968908?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?